Clinical Trial Update: Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol [Phase 4]

View source ↗

Summary

Phase 4 trial comparing calcitriol versus paricalcitol for management of mineral and bone disorders in hemodialysis, terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Hyperparathyroidism
• Hyperphosphatemia
• Kidney Failure

Drugs mentioned

• Calcitriol (calcitriol)
• Paricalcitol (paricalcitol)

Snippet

Sponsor: Winthrop University Hospital | Conditions: Kidney Failure, Secondary Hyperparathyroidism | Phase 4 | Status: TERMINATED | Results posted: 2023-11-07